Effect of multiple invasive foci on breast cancer outcomes according to the molecular subtypes: A report from the Korean breast cancer society

Annals of Oncology

Volumn 24, Issue 9, 2013, Pages 2298-2304

  Moon, H G ^a   Han, W ^a   Kim, J Y ^a,f   Kim, S J ^b   Yoon, J H ^c   Oh, S J ^d   Yu, J H ^e   Noh, D Y ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Inha University Hospital   (South Korea)

^c Chonnam National University Hwasun Hospital and Medical School   (South Korea)

^d Bupyeong gu   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f Gyeongsang National University   (South Korea)

Author keywords

Breast cancer; Molecular subtype; Multicentricity; Multifocality; Prognosis

Indexed keywords

ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER CELL; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CELL ACTIVITY; DISEASE ASSOCIATION; DISTANT METASTASIS; HAZARD RATIO; HUMAN; KOREA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CANCER; NON PROFIT ORGANIZATION; OVERALL SURVIVAL; POPULATION RESEARCH; PRIMARY TUMOR; PRIORITY JOURNAL; TREATMENT OUTCOME; TRIPLE NEGATIVE BREAST CANCER; TUMOR INVASION; TUMOR VOLUME;

BREAST CANCER; MOLECULAR SUBTYPE; MULTICENTRICITY; MULTIFOCALITY; PROGNOSIS;

DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; REPUBLIC OF KOREA; SURVIVAL; TREATMENT OUTCOME; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84883417451     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt187     Document Type: Article

References (30)

1. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63: 181-187.
2. Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin 2006; 56: 37-47.
3. Goldhirsch A, Wood WC, Coates AS et al. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the primary therapy of Early Breast Cancer 2011. Ann Oncol 2011; 22: 1736-1747.
4. Andea AA, Bouwman D, Wallis T et al. Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Cancer 2003; 100: 20-27.
5. Cabioglu N, Ozmen V, Kaya H et al. Increased lymph node positivity in multifocal and multicentric breast cancer. J Am Coll Surg 2009; 208: 67-74.
6. Coombs NJ. Multifocal and multicentric breast cancer: does each focus matter? J Clin Oncol 2005; 23: 7497-7502.
7. Joergensen LE, Gunnarsdottir KA, Lanng C et al. Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996-2001. Breast 2008; 17: 587-591.
8. Pedersen L, Gunnarsdottir KA, Rasmussen BB et al. The prognostic influence of multifocality in breast cancer patients. Breast 2004; 13: 188-193.
9. Vlastos G, Rubio IT, Mirza NQ et al. Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer. Ann Surg Oncol 2000; 7: 581-587.
10. Fish EB, Chapman JA, Link MA. Assessment of tumor size for multifocal primary breast cancer. Ann Surg Oncol 1998; 5: 442-446.
11. O'Daly BJ, Sweeney KJ, Ridgway PF et al. The accuracy of combined versus largest diameter in staging multifocal breast cancer. J American Coll Surg 2007; 204: 282-285.
12. Park YH, Lee SJ, Cho EY et al. Clinical relevance of TNM staging system according to breast cancer subtypes. Ann Oncol 2011; 22: 1554-1560.
13. Wirapati P, Sotiriou C, Kunkel S et al. Meta-analysis of gene-expression profiles in breast cancer: toward a unified understanding of breast cancer sub-typing and prognosis signatures. Breast Cancer Res 2008; 10: R65.
14. Wo JY, Chen K, Neville BA et al. Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer. J Clin Oncol 2011; 29: 2619-2627.
15. Moon HG, Han W, Noh DY. Underweight and breast cancer recurrence and death: a report from the Korean Breast Cancer Society. J Clin Oncol 2009; 27: 5899-905.
16. Lagios MD, Westdahl PR, Rose MR. The concept and implications of multicentricity in breast carcinoma. Pathol Annu 1981; 16: 83-102.
17. Jung KW, Park S, Won YJ et al. Prediction of cancer incidence and mortality in Korea, 2012. Cancer Res Treat 2012; 44: 25-31.
18. Carey LA, Dees EC, Sawyer L et al. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 2007; 13: 2329-34.
19. Foulkes WD, Reis-Filho JS, Narod SA. Tumor size and survival in breast cancer-a reappraisal. Nature Publishing Group 2010; 7: 348-353.
20. Michaelson JS, Silverstein M, Wyatt J et al. Predicting the survival of patients with breast carcinoma using tumor size. Cancer 2002; 95: 713-723.
21. Egan RL. Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer 1982; 49: 1123-1130.
22. Katz A, Strom EA, Buchholz TA et al. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol, Biol, Phys 2001; 50: 735-742.
23. Middleton LP, Vlastos G, Mirza NQ et al. Multicentric mammary carcinoma. Cancer 2002; 94: 1910-1916.
24. Rezo A, Dahlstrom J, Shadbolt B et al. Tumor size and survival in multicentric and multifocal breast cancer. Breast 2011; 20: 259-263.
25. Desmedt C, Haibe-Kains B, Wirapati P et al. Biological processes associated with breast cancer clinical outcome depend on the molecularsSubtypes. Clin Cancer Res 2008; 14: 5158-5165.
26. Dent R, Trudeau M, Pritchard KI et al. Triple-negative breast cancer: clinical features and atterns of Recurrence. Clin Cancer Res 2007; 13: 4429-4434.
27. Foulkes WD, Grainge MJ, Rakha EA et al. Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status. Breast Cancer Res Treat 2008; 117: 199-204.
28. Foulkes WD, Metcalfe K, Hanna W et al. Disruption of the expected positive correlation between breast tumor size and lymph node status inBRCA1-related breast carcinoma. Cancer 2003; 98: 1569-1577.
29. Hernandez-Aya LF, Chavez-Macgregor M, Lei X et al. Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer. J Clin Oncol 2011; 29: 2628-2634.
30. Jain S, Rezo A, Shadbolt B et al. Synchronous multiple ipsilateral breast cancers: implications for patient management. Pathology 2009; 41: 57-67.